Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

staurosporine has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Elkamhawy, A; Farag, AK; Lee, KT; Londhe, AM; Pae, AN; Roh, EJ1
Aisen, PS; Mukherjee, P; Pasinetti, GM; Rachita, C1
Brüne, B; Schmid, T; Schnitzer, SE; Zhou, J1
Chen, X; Fan, Y; Guo, N; Han, J; Yang, B; Zhang, L1

Other Studies

5 other study(ies) available for staurosporine and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.
    European journal of medicinal chemistry, 2017, Dec-01, Volume: 141

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cell Survival; Dose-Response Relationship, Drug; Inflammation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; RAW 264.7 Cells; Receptors, Colony-Stimulating Factor; Structure-Activity Relationship

2017
Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death.
    Clinical and experimental rheumatology, 2001, Volume: 19, Issue:1 Suppl 22

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Cell Line; Cell Nucleus; Cell Survival; Chondrocytes; Cyclooxygenase Inhibitors; Cytochrome c Group; Dose-Response Relationship, Drug; Ibuprofen; Nitrobenzenes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; RNA, Messenger; Staurosporine; Sulfonamides; Time Factors

2001
Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis.
    Cell death and differentiation, 2006, Volume: 13, Issue:9

    Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cobalt; Cyclooxygenase 2; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Membrane Proteins; Nitrobenzenes; RNA, Small Interfering; Staurosporine; Sulfonamides

2006
Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
    Experimental biology and medicine (Maywood, N.J.), 2014, Volume: 239, Issue:3

    Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Fibrosis; Glomerular Mesangium; Mesangial Cells; Nitrobenzenes; Protein Transport; Rats; RNA, Messenger; Signal Transduction; Smad3 Protein; Smad7 Protein; Staurosporine; Sulfonamides; Thromboxane A2; Transforming Growth Factor beta; Tretinoin

2014